Suppr超能文献

LncRNA-CYTOR 与 Wnt/β-连环蛋白信号之间的正反馈环促进结肠癌转移。

A Positive Feed-Forward Loop between LncRNA-CYTOR and Wnt/β-Catenin Signaling Promotes Metastasis of Colon Cancer.

机构信息

Department of Gastrointestinal Surgery, Renji Hospital, School of Medicine, Shanghai Jiao Tong University, Shanghai 200127, China.

Department of Gastric Surgery, Fudan University Shanghai Cancer Center, Shanghai 200032, China; Department of Oncology, Shanghai Medical College, Fudan University, Shanghai 200032, China.

出版信息

Mol Ther. 2018 May 2;26(5):1287-1298. doi: 10.1016/j.ymthe.2018.02.024. Epub 2018 Mar 6.

Abstract

We previously demonstrated that long non-coding RNA cytoskeleton regulator RNA (CYTOR), also known as Linc00152, was significantly overexpressed in colon cancer and conferred resistance to oxaliplatin-induced apoptosis. At the same time, elevated CYTOR expression was also reported in gastric cancer and exerted influences on epithelial-mesenchymal transition (EMT) markers. However, the precise mechanism by which CYTOR promotes the EMT phenotype and cancer metastasis remains poorly understood. Here, we showed that loss of epithelial characteristics and simultaneous gain of mesenchymal features correlated with CYTOR expression. Knockdown of CYTOR attenuated colon cancer cell migration and invasion. Conversely, ectopic expression of CYTOR induced an EMT program and enhanced metastatic properties of colon cancer cells. Mechanistically, the binding of CYTOR to cytoplasmic β-catenin impeded casein kinase 1 (CK1)-induced β-catenin phosphorylation that enabled it to accumulate and translocate to the nucleus. Reciprocally, β-catenin/TCF complex enhanced the transcription activity of CYTOR in nucleus, thus forming a positive feed-forward circuit. Moreover, elevated CYTOR, alone or combined with overexpression of nuclear β-catenin, was predictive of poor prognosis. Our findings suggest that CYTOR promotes colon cancer EMT and metastasis by interacting with β-catenin, and the positive feed-forward circuit of CYTOR-β-catenin might be a useful therapeutic target in antimetastatic strategy.

摘要

我们之前的研究表明,长链非编码 RNA 细胞骨架调节 RNA(也称为 Linc00152)在结肠癌中显著过表达,并赋予其对奥沙利铂诱导的细胞凋亡的抗性。同时,在胃癌中也报道了升高的 CYTOR 表达,并对上皮-间充质转化(EMT)标志物产生影响。然而,CYTOR 促进 EMT 表型和癌症转移的确切机制仍知之甚少。在这里,我们表明上皮特征的丧失和同时获得间充质特征与 CYTOR 表达相关。敲低 CYTOR 减弱了结肠癌细胞的迁移和侵袭。相反,CYTOR 的异位表达诱导 EMT 程序并增强结肠癌细胞的转移特性。从机制上讲,CYTOR 与细胞质 β-连环蛋白结合,阻碍了酪蛋白激酶 1(CK1)诱导的 β-连环蛋白磷酸化,使其能够积累并易位到细胞核。反过来,β-连环蛋白/TCF 复合物增强了 CYTOR 在核内的转录活性,从而形成正反馈回路。此外,升高的 CYTOR,单独或与核 β-连环蛋白的过表达一起,预示着预后不良。我们的研究结果表明,CYTOR 通过与 β-连环蛋白相互作用促进结肠癌细胞 EMT 和转移,并且 CYTOR-β-连环蛋白的正反馈回路可能是抗转移策略中的一个有用的治疗靶点。

相似文献

1
A Positive Feed-Forward Loop between LncRNA-CYTOR and Wnt/β-Catenin Signaling Promotes Metastasis of Colon Cancer.
Mol Ther. 2018 May 2;26(5):1287-1298. doi: 10.1016/j.ymthe.2018.02.024. Epub 2018 Mar 6.
3
Wnt3a expression is associated with epithelial-mesenchymal transition and promotes colon cancer progression.
J Exp Clin Cancer Res. 2014 Dec 11;33(1):107. doi: 10.1186/s13046-014-0107-4.
5
PMA treated THP-1-derived-IL-6 promotes EMT of SW48 through STAT3/ERK-dependent activation of Wnt/β-catenin signaling pathway.
Biomed Pharmacother. 2018 Dec;108:618-624. doi: 10.1016/j.biopha.2018.09.067. Epub 2018 Sep 20.
6
RHBDD1 promotes colorectal cancer metastasis through the Wnt signaling pathway and its downstream target ZEB1.
J Exp Clin Cancer Res. 2018 Feb 9;37(1):22. doi: 10.1186/s13046-018-0687-5.
7
LncRNA SLCO4A1-AS1 facilitates growth and metastasis of colorectal cancer through β-catenin-dependent Wnt pathway.
J Exp Clin Cancer Res. 2018 Sep 10;37(1):222. doi: 10.1186/s13046-018-0896-y.
8
Cinobufacini Inhibits Colon Cancer Invasion and Metastasis via Suppressing Wnt/β-Catenin Signaling Pathway and EMT.
Am J Chin Med. 2020;48(3):703-718. doi: 10.1142/S0192415X20500354. Epub 2020 Apr 24.
10
Inhibition of PRRX2 suppressed colon cancer liver metastasis via inactivation of Wnt/β-catenin signaling pathway.
Pathol Res Pract. 2019 Oct;215(10):152593. doi: 10.1016/j.prp.2019.152593. Epub 2019 Aug 11.

引用本文的文献

1
Emerging implications of N6-methyladenosine in prostate cancer progression and treatment.
Cell Death Discov. 2025 Aug 19;11(1):391. doi: 10.1038/s41420-025-02680-w.
2
Novel Molecular Signatures Selectively Predict Clinical Outcomes in Colon Cancer.
Cancers (Basel). 2025 Mar 7;17(6):919. doi: 10.3390/cancers17060919.
3
lncRNAlyzr: Enrichment Analysis for lncRNA Sets.
J Mol Biol. 2025 Aug 1;437(15):168938. doi: 10.1016/j.jmb.2025.168938. Epub 2025 Jan 11.
6
Delivery of A Chemically Modified Noncoding RNA Domain Improves Dystrophic Myotube Function.
Adv Sci (Weinh). 2025 May;12(20):e2410908. doi: 10.1002/advs.202410908. Epub 2025 Feb 17.
7
Long non‑coding RNA signatures in breast cancer: Properties as biomarkers?
Exp Ther Med. 2025 Jan 22;29(3):54. doi: 10.3892/etm.2025.12804. eCollection 2025 Mar.
9
10
Reduced Proline-Rich Tyrosine Kinase 2 Promotes Tumor Metastasis by Activating Epithelial-Mesenchymal Transition in Colorectal Cancer.
Dig Dis Sci. 2024 Nov;69(11):4098-4107. doi: 10.1007/s10620-024-08643-y. Epub 2024 Oct 16.

本文引用的文献

2
Notch-4 silencing inhibits prostate cancer growth and EMT via the NF-κB pathway.
Apoptosis. 2017 Jun;22(6):877-884. doi: 10.1007/s10495-017-1368-0.
4
Long non-coding RNAs: a rising biotarget in colorectal cancer.
Oncotarget. 2017 Mar 28;8(13):22187-22202. doi: 10.18632/oncotarget.14728.
6
ADNP Is a Therapeutically Inducible Repressor of WNT Signaling in Colorectal Cancer.
Clin Cancer Res. 2017 Jun 1;23(11):2769-2780. doi: 10.1158/1078-0432.CCR-16-1604. Epub 2016 Nov 30.
8
The degradation of EZH2 mediated by lncRNA ANCR attenuated the invasion and metastasis of breast cancer.
Cell Death Differ. 2017 Jan;24(1):59-71. doi: 10.1038/cdd.2016.95. Epub 2016 Oct 7.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验